Search research articles
Contact Us
Filters
Showing results (261-270 of 271) with videos related to
Page
of 28
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2025
Low-Dose Fractionated Radiation Therapy as a Chemopotentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase 1/2 Trial
Timothy Lin, Suqi Ke, Chen Hu, et al.
Cancer Immunology Research
|
August 30, 2017
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis
Rajeev K Shrimali, Shamim Ahmad, Vivek Verma, et al.
Signal Transduction and Targeted Therapy
|
January 16, 2026
Extracellular vesicle-derived miRNA-182-5p educates macrophages towards an immunosuppressive phenotype in pancreatic cancer
Baldev Singh, Pankaj Gaur, Pritha Bose, et al.
Nature Immunology
|
January 12, 2026
PARP inhibition generates enhanced CD8<sup>+</sup> central memory T cells by transcriptional and metabolic reprogramming
Wael Traboulsi, Pankaj Gaur, Subhadip Kundu, et al.
Nature Communications
|
December 21, 2018
Integrin CD11b activation drives anti-tumor innate immunity
Michael C Schmid, Samia Q Khan, Megan M Kaneda, et al.
Nature Immunology
|
November 24, 2020
MEK inhibition reprograms CD8<sup>+</sup> T lymphocytes into memory stem cells with potent antitumor effects
Vivek Verma, Nazli Jafarzadeh, Shannon Boi, et al.
Leukemia
|
July 13, 2024
Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma
Udita Jindal, Mukesh Mamgain, Uttam Kumar Nath, et al.
Nature Immunology
|
July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistance
Vivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Immunology
|
September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistance
Vivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
JAMA Network Open
|
July 16, 2025
AI Workflow, External Validation, and Development in Eye Disease Diagnosis
Qingyu Chen, Tiarnan D L Keenan, Elvira Agron, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 271) with videos related to
Sort By:
Page
of 28
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2025
Low-Dose Fractionated Radiation Therapy as a Chemopotentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase 1/2 Trial
Timothy Lin, Suqi Ke, Chen Hu, et al.
Cancer Immunology Research
|
August 30, 2017
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis
Rajeev K Shrimali, Shamim Ahmad, Vivek Verma, et al.
Signal Transduction and Targeted Therapy
|
January 16, 2026
Extracellular vesicle-derived miRNA-182-5p educates macrophages towards an immunosuppressive phenotype in pancreatic cancer
Baldev Singh, Pankaj Gaur, Pritha Bose, et al.
Nature Immunology
|
January 12, 2026
PARP inhibition generates enhanced CD8<sup>+</sup> central memory T cells by transcriptional and metabolic reprogramming
Wael Traboulsi, Pankaj Gaur, Subhadip Kundu, et al.
Nature Communications
|
December 21, 2018
Integrin CD11b activation drives anti-tumor innate immunity
Michael C Schmid, Samia Q Khan, Megan M Kaneda, et al.
Nature Immunology
|
November 24, 2020
MEK inhibition reprograms CD8<sup>+</sup> T lymphocytes into memory stem cells with potent antitumor effects
Vivek Verma, Nazli Jafarzadeh, Shannon Boi, et al.
Leukemia
|
July 13, 2024
Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma
Udita Jindal, Mukesh Mamgain, Uttam Kumar Nath, et al.
Nature Immunology
|
July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistance
Vivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Immunology
|
September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistance
Vivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
JAMA Network Open
|
July 16, 2025
AI Workflow, External Validation, and Development in Eye Disease Diagnosis
Qingyu Chen, Tiarnan D L Keenan, Elvira Agron, et al.
Page
of 28